Site icon pharmaceutical daily

Alcohol Addiction – Pipeline Review, H1 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Alcohol
Addiction – Pipeline Review, H1 2019”
drug pipelines has been
added to ResearchAndMarkets.com’s offering.

This latest Pharmaceutical and Healthcare disease pipeline guide, Alcohol
Addiction – Pipeline Review, H1 2019
, provides an overview of the
Alcohol Addiction (Central Nervous System) pipeline landscape.

Alcohol addiction refers to a psychological and physical dependency on
alcohol. Symptoms include decreased involvement in extracurricular
activities, depression, restlessness, inability to control drinking and
violent behavior. Risk factors include age, family history and
depression and other mental health problems.

Report Highlights

This latest pipeline guide Alcohol Addiction – Pipeline Review, H1 2019,
provides comprehensive information on the therapeutics under development
for Alcohol Addiction (Central Nervous System), complete with analysis
by stage of development, drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type. The guide covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.

The Alcohol Addiction (Central Nervous System) pipeline guide also
reviews of key players involved in therapeutic development for Alcohol
Addiction and features dormant and discontinued projects. The guide
covers therapeutics under Development by Companies /Universities
/Institutes, the molecules developed by Companies in Phase III, Phase
II, Phase I, Preclinical and Unknown stages are 1, 9, 7, 20 and 1
respectively. Similarly, the Universities portfolio in Preclinical
stages comprises 4 molecules, respectively.

Alcohol Addiction (Central Nervous System) pipeline guide helps in
identifying and tracking emerging players in the market and their
portfolios, enhances decision making capabilities and helps to create
effective counter strategies to gain competitive advantage.

Scope:

Reasons to Buy

Key Topics Covered

  1. Introduction
  2. Alcohol Addiction – Overview
  3. Alcohol Addiction – Therapeutics Development
  4. Alcohol Addiction – Therapeutics Assessment
  5. Alcohol Addiction – Companies Involved in Therapeutics Development
  6. Alcohol Addiction – Drug Profiles
  7. Alcohol Addiction – Dormant Projects
  8. Alcohol Addiction – Discontinued Products
  9. Alcohol Addiction – Product Development Milestones
  10. Appendix

Companies Mentioned

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/8p33jn/alcohol_addiction?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Addiction
Disorders Drugs

Exit mobile version